Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage Ib Lung Carcinoma”

471 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 471 results

Early research (Phase 1)Study completedNCT00599755
What this trial is testing

Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)

Who this might be right for
CarcinomaNon-small Cell Lung Cancer
Merck Sharp & Dohme LLC 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07285148
What this trial is testing

Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerEGFR MutationMetastatic Lung Cancer+1 more
Beijing Pearl Biotechnology Limited Liability Company 253
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07407933
What this trial is testing

YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

Who this might be right for
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd. 118
Not applicableStudy completedNCT03091816
What this trial is testing

Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+1 more
University of Southern California 15
Early research (Phase 1)Study completedNCT04041011
What this trial is testing

SHR-1316 and Fluzoparib（SHR-3162） in Small Cell Lung Cancer Patients

Who this might be right for
Small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 23
Early research (Phase 1)Study completedNCT02457793
What this trial is testing

The Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Cancers, Melanoma
Genentech, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00290355
What this trial is testing

Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 182
Testing effectiveness (Phase 2)Ended earlyNCT02335944
What this trial is testing

Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer
Novartis Pharmaceuticals 177
Early research (Phase 1)Study completedNCT02185690
What this trial is testing

A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung

Who this might be right for
Lungcancer
University Health Network, Toronto 13
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Early research (Phase 1)Looking for participantsNCT04780568
What this trial is testing

Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more
Ohio State University Comprehensive Cancer Center 24
Early research (Phase 1)Ended earlyNCT04261439
What this trial is testing

A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab

Who this might be right for
In Escalation: All Patients With Solid Tumors and LymphomaIn Expansion: Melanoma, Non-small Cell Lung Cancer
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07172412
What this trial is testing

Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell Cancer
Tianjin Medical University Cancer Institute and Hospital 165
Large-scale testing (Phase 3)Looking for participantsNCT04316364
What this trial is testing

A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 537
Testing effectiveness (Phase 2)Looking for participantsNCT05528458
What this trial is testing

Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma
Samsung Medical Center 59
Early research (Phase 1)Ended earlyNCT04348292
What this trial is testing

Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+7 more
Emory University 3
Early research (Phase 1)Looking for participantsNCT06969612
What this trial is testing

A Study on the Efficacy and Safety of Golidocitinib Combined With Tislelizumab and Chemotherapy as First-line Treatment for Advanced NSCLC

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Peking University Cancer Hospital & Institute 21
Testing effectiveness (Phase 2)Study completedNCT01126736
What this trial is testing

Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eisai Inc. 98
Testing effectiveness (Phase 2)Looking for participantsNCT07371663
What this trial is testing

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

Who this might be right for
Solid CancersNSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer+2 more
Beijing Tide Pharmaceutical Co., Ltd 266
Testing effectiveness (Phase 2)Looking for participantsNCT04210492
What this trial is testing

Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Yale University 36
Load More Results